Cargando…

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey

OBJECTIVE: We investigated the impact of multimorbidity and polypharmacy on the management of atrial fibrillation (AF) patients in clinical practice and assessed factors associated with polypharmacy and oral anticoagulation (OAC) use in AF patients with multimorbidity and polypharmacy. METHODS: A 14...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozieł, Monika, Simovic, Stefan, Pavlovic, Nikola, Kocijancic, Aleksandar, Paparisto, Vilma, Music, Ljilja, Trendafilova, Elina, Dan, Anca Rodica, Kusljugic, Zumreta, Dan, Gheorghe-Andrei, Lip, Gregory Y. H., Potpara, Tatjana S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Cardiology & Cardiovascular Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877933/ https://www.ncbi.nlm.nih.gov/pubmed/32700579 http://dx.doi.org/10.1080/07853890.2020.1799241

Ejemplares similares

Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey
por: Kozieł, Monika, et al.
Publicado: (2020)

Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey
por: Kozieł, Monika, et al.
Publicado: (2019)

Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey
por: Potpara, Tatjana S., et al.
Publicado: (2016)

The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey
por: Potpara, Tatjana S., et al.
Publicado: (2017)

Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach
por: Kozieł-Siołkowska, Monika, et al.
Publicado: (2022)

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
por: Proietti, Marco, et al.
Publicado: (2021)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Improvements in Neonatal and Childhood Medical Care – Perspective from the Balkans
por: Velickovic, Vesna, et al.
Publicado: (2015)

Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry
por: Proietti, Marco, et al.
Publicado: (2021)

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
por: Pope, Marita Knudsen, et al.
Publicado: (2021)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
por: Kozieł, Monika, et al.
Publicado: (2020)

Rhythm Control in AF: Have We Reached the Last Frontier?
por: Dan, Gheorghe-Andrei
Publicado: (2019)

Balkan endemic nephropathy—current status and future perspectives
por: Pavlović, Nikola M.
Publicado: (2013)

Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study
por: Potpara, Tatjana S, et al.
Publicado: (2013)

Direct coronary stenting in reducing radiation and radiocontrast consumption
por: Caluk, Jasmin, et al.
Publicado: (2010)

The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation
por: Naser, Nabil, et al.
Publicado: (2017)

Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
por: von Buedingen, Fiona, et al.
Publicado: (2018)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
por: van den Akker, Marjan, et al.
Publicado: (2019)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
por: Romiti, Giulio Francesco, et al.
Publicado: (2022)

The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation
por: Naser, Nabil, et al.
Publicado: (2017)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Balkan Express
Publicado: (1986)

The Balkan Nephropathy
por: Freedman, Lawrence R.
Publicado: (1968)

Balkan nephropathy
por: DjukanoviĆ, Ljubica, et al.
Publicado: (2008)

Balkan Nephropathy
Publicado: (1977)

Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator
por: Assari, Shervin, et al.
Publicado: (2019)

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k8rmohamqja8gt9qft4dn0ihhk